Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax
Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax
Active, not recruiting · NCT05192889 · Registry updated 2025-09-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Active, not recruiting | Phase 1 / Phase 2 | 2025-09-22 | NCT05192889 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AbbVie | 340 |
| St. Jude Children's Research Hospital | 169 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| St. Jude Children's Research Hospital | Memphis | United States | 194 |